STOCK TITAN

OrthoPediatrics Corp. - KIDS STOCK NEWS

Welcome to our dedicated page for OrthoPediatrics news (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on OrthoPediatrics stock.

OrthoPediatrics Corp. (symbol: KIDS) is a global leader in pediatric orthopedics, exclusively focusing on providing innovative solutions for children with orthopedic conditions and injuries. The company is dedicated to advancing pediatric orthopedics by developing state-of-the-art technologies, ensuring high-quality products, and offering unparalleled support and clinical education through its team of experts.

OrthoPediatrics offers a wide range of anatomically appropriate implants and instruments designed to meet the unique needs of pediatric orthopedic surgeons. Their product portfolio includes solutions for long bone deformity correction and trauma, spine, and sports medicine. Among their flagship products are PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and the ACL Reconstruction System.

Recent achievements of OrthoPediatrics include issuing the 2024 financial guidance and recording a full-year revenue of $148.7 million in 2023, marking a 22% increase compared to the previous year. As of December 31, 2023, the company had cash and cash equivalents, short-term investments, and restricted cash totaling $82.3 million. The recent acquisition of Boston Orthotics & Prosthetics was a significant milestone, further reinforcing their market position.

In the first quarter of 2024, OrthoPediatrics reported a 41% increase in revenue year-over-year. The company's total other expense was $0.6 million for the quarter, primarily due to a favorable fair value adjustment in the previous year that did not recur in 2024, as well as additional interest expenses related to a new term loan with MidCap. As of March 31, 2024, the company's cash, cash equivalents, short-term investments, and restricted cash were $49.7 million.

OrthoPediatrics continues to seek talented professionals to join their mission. Interested candidates can visit their website to learn about current openings or submit their resumes to careers@orthopediatrics.com. For the latest updates, news, and developments, shareholders and potential investors can find the most recent information on OrthoPediatrics Corp. through this page.

Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced participation in three virtual investor conferences in November 2020. Key executives, including CEO Mark Throdahl and COO Fred Hite, will represent the company. The events include the Credit Suisse 29th Annual Virtual Healthcare Conference on November 11, Stifel 2020 Virtual Healthcare Conference on November 18, and Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum on November 19. Investors can access the audio webcast on OrthoPediatrics' investor relations site.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.23%
Tags
conferences
-
Rhea-AI Summary

OrthoPediatrics Corp. (NASDAQ: KIDS) will release its third quarter 2020 financial results on November 4, 2020, after the market closes. A conference call to discuss these results is scheduled for November 5, 2020, at 8:00 a.m. ET. Interested participants can join the call using the provided domestic and international dial-in numbers. OrthoPediatrics, founded in 2006, focuses on pediatric orthopedics, offering 35 surgical systems across multiple categories and serving markets in the U.S. and 43 other countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.38%
Tags
conferences earnings
-
Rhea-AI Summary

OrthoPediatrics Corp. (KIDS) announced its support for the 3rd Annual PediOrtho WEST Resident Education Course, scheduled for October 16-17 in Sacramento, California. The course aims to provide orthopedic residents with essential training in pediatric orthopedic techniques through both lectures and hands-on labs, facilitated by expert surgeons. President David Bailey emphasized the company's commitment to advancing pediatric orthopedic education globally, enhancing outcomes for aspiring surgeons.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.37%
Tags
none
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announces continued support for the Scoliosis Research Society (SRS) with Gold Level sponsorship for its 55th Annual Meeting, running virtually from September 9-13. Additionally, the company will be a Platinum Level Sponsor for the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) 74th Annual Meeting from September 23-26. OrthoPediatrics will offer educational grants and scholarships for physicians attending these events, contributing to discussions and showcasing its products through virtual exhibits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.2%
Tags
none
-
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced participation in the Morgan Stanley 18th Annual Global Healthcare Conference on September 15, 2020. Key executives, including CEO Mark Throdahl and CFO Fred Hite, will engage in a fireside chat and one-on-one meetings starting at 4:15 PM ET. The event will take place virtually, with an audio webcast accessible on the company’s investor relations website. OrthoPediatrics specializes in pediatric orthopedic products, boasting 35 surgical systems for trauma, scoliosis, and sports medicine across 43 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
conferences
-
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced the completion of its 1,000th surgery using the Pediatric Nailing Platform | FEMUR (PNP | FEMUR), a system designed for pediatric femur fracture treatment. This innovative intramedullary nailing system, which received FDA 510(k) clearance in 2018, addresses specific anatomical needs of children and adolescents. With a comprehensive range of sizes and instrumentation, the PNP system represents OrthoPediatrics' commitment to improving pediatric orthopedic solutions, building on nearly a decade of learning from its original PediNail system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.48%
Tags
none
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) has announced its sponsorship for the virtual 30th Annual Baltimore Limb Deformity Course (BLDC) on August 29-30, 2020. The company will provide scholarships for residents and fellows to access the course. Utilizing its DocMatter and VuMedi platforms, OrthoPediatrics will share educational video content on its innovative Orthex frame, aimed at correcting limb deformities. CEO Mark Throdahl emphasized the importance of BLDC for pediatric surgeons and the effectiveness of virtual interactions in advancing orthopedic care for children.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
none
-
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced participation in the 5th Annual Needham Virtual Med Tech 1x1 Conference. CEO Mark Throdahl, COO Fred Hite, and President Dave Bailey will host virtual investor meetings on August 17, 2020. Interested investors can schedule one-on-one calls by contacting their Needham representative or Emma Poalillo at The Ruth Group.

Founded in 2006, OrthoPediatrics focuses on pediatric orthopedics, offering 35 surgical systems across trauma, scoliosis, and sports medicine categories. The company operates globally, serving the U.S. and 43 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.74%
Tags
conferences
-
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) reported a 25.3% decline in total revenue for the second quarter of 2020, amounting to $13.6 million, largely due to the effects of the COVID-19 pandemic. U.S. revenue decreased by 12.3% to $12.1 million, while international revenue plummeted 66.8% to $1.4 million. Despite challenges, the company initiated the U.S. launch of the ApiFix system and expanded its sales team by 7.9%. Operating loss increased to ($7.0 million), compared to ($1.8 million) last year, while net loss was ($9.4 million), leading to a net loss per share of ($0.54).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) has achieved a milestone by completing its 500th case using the FIREFLY® Pedicle Screw Navigation Guides in collaboration with Mighty Oak Medical. This technology enhances surgical efficiency and patient safety by utilizing AI for presurgical planning. It reduces intraoperative radiation and speeds up screw placement, making it a cost-effective alternative to traditional navigation systems. The technology is designed specifically for pediatric orthopedic surgeries, aiming to improve outcomes for children with scoliosis and spinal deformities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
none

FAQ

What is the current stock price of OrthoPediatrics (KIDS)?

The current stock price of OrthoPediatrics (KIDS) is $26.34 as of November 22, 2024.

What is the market cap of OrthoPediatrics (KIDS)?

The market cap of OrthoPediatrics (KIDS) is approximately 637.8M.

What does OrthoPediatrics Corp. do?

OrthoPediatrics Corp. designs, develops, and commercializes implants and instruments specifically for pediatric orthopedic surgeons to treat children with orthopedic conditions and injuries.

What are some of OrthoPediatrics' key products?

Key products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and the ACL Reconstruction System.

What were OrthoPediatrics' financial highlights for 2023?

OrthoPediatrics recorded a full-year revenue of $148.7 million in 2023, a 22% increase compared to the prior year.

How did OrthoPediatrics perform in the first quarter of 2024?

In the first quarter of 2024, OrthoPediatrics reported a 41% increase in revenue year-over-year, with total other expense at $0.6 million.

What recent acquisition did OrthoPediatrics make?

OrthoPediatrics recently acquired Boston Orthotics & Prosthetics, further reinforcing their market position.

How much cash and equivalents did OrthoPediatrics have as of March 31, 2024?

As of March 31, 2024, OrthoPediatrics had $49.7 million in cash, cash equivalents, short-term investments, and restricted cash.

What is OrthoPediatrics' focus in pediatric orthopedics?

OrthoPediatrics focuses on advancing pediatric orthopedics by developing state-of-the-art technologies, high-quality products, and offering industry-leading support and clinical education.

Where can I learn about career opportunities at OrthoPediatrics?

You can learn about current openings and career opportunities at OrthoPediatrics by visiting their website or submitting a resume to careers@orthopediatrics.com.

Who can I contact for investor relations at OrthoPediatrics?

For investor relations, you can contact Philip Taylor at Gilmartin Group via email at philip@gilmartinir.com or phone at 415-937-5406.

What recent financial guidance did OrthoPediatrics issue?

OrthoPediatrics recently issued their 2024 financial guidance, which includes detailed projections and expectations for the year.

OrthoPediatrics Corp.

Nasdaq:KIDS

KIDS Rankings

KIDS Stock Data

637.85M
16.34M
32.52%
70.85%
3.77%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
WARSAW